Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zoppetti

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Veterinary Pharmacology and Therapeutics|April 1, 2016
Topical delivery of diclofenac into and across equine skin from a novel liquid diclofenac epolamine formulationS Del Río-Sancho, D Concas, P Oreste, et al.
The New Microbiologica|January 14, 2005
Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmissionF Pacciarini, S Ghezzi, D Pinna, et al.
European Journal of Biochemistry|May 15, 1993
Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studiesD Coltrini, M Rusnati, G Zoppetti, et al.
AIDS Research and Human Retroviruses|July 1, 1994
Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activityL Lopalco, F Ciccomascolo, P Lanza, et al.
Clinical and Experimental Immunology|April 1, 1984
Serum autoantibodies and thyroid lymphocytic infiltration in endemic goitreA Costa, V de Filippis, A Balsamo, et al.
The Biochemical Journal|September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studiesB Casu, P Oreste, G Torri, et al.
The Journal of Biological Chemistry|July 27, 2001
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivativesD Leali, M Belleri, C Urbinati, et al.
The Journal of Biological Chemistry|April 25, 1997
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and sizeM Rusnati, D Coltrini, P Oreste, et al.
Arzneimittel-Forschung|January 1, 1983
Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphatesB Casu, E A Johnson, M Mantovani, et al.
Carbohydrate Research|October 17, 1994
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5B Casu, G Grazioli, N Razi, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Veterinary Pharmacology and Therapeutics|April 1, 2016
Topical delivery of diclofenac into and across equine skin from a novel liquid diclofenac epolamine formulationS Del Río-Sancho, D Concas, P Oreste, et al.
The New Microbiologica|January 14, 2005
Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmissionF Pacciarini, S Ghezzi, D Pinna, et al.
European Journal of Biochemistry|May 15, 1993
Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studiesD Coltrini, M Rusnati, G Zoppetti, et al.
AIDS Research and Human Retroviruses|July 1, 1994
Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activityL Lopalco, F Ciccomascolo, P Lanza, et al.
Clinical and Experimental Immunology|April 1, 1984
Serum autoantibodies and thyroid lymphocytic infiltration in endemic goitreA Costa, V de Filippis, A Balsamo, et al.
The Biochemical Journal|September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studiesB Casu, P Oreste, G Torri, et al.
The Journal of Biological Chemistry|July 27, 2001
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivativesD Leali, M Belleri, C Urbinati, et al.
The Journal of Biological Chemistry|April 25, 1997
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and sizeM Rusnati, D Coltrini, P Oreste, et al.
Arzneimittel-Forschung|January 1, 1983
Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphatesB Casu, E A Johnson, M Mantovani, et al.
Carbohydrate Research|October 17, 1994
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5B Casu, G Grazioli, N Razi, et al.
Pageof 4